These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 28216783)

  • 21. Clinical practice variations in prescribing antipsychotics for patients with schizophrenia.
    Owen RR; Fischer EP; Kirchner JE; Thrush CR; Williams DK; Cuffel BJ; Elliott CE; Booth BM
    Am J Med Qual; 2003; 18(4):140-6. PubMed ID: 12934949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative evaluation of clinical practice guidelines for the treatment of schizophrenia].
    Delessert D; Pomini V; Grasset F; Baumann P
    Encephale; 2008 Jan; 34(1):93-100. PubMed ID: 18514156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implementation of a clinical practice guideline for schizophrenia in a specialist mental health center: an observational study.
    Fischler I; Riahi S; Stuckey MI; Klassen PE
    BMC Health Serv Res; 2016 Aug; 16(a):372. PubMed ID: 27514778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance.
    Hasan A; Falkai P; Wobrock T; Lieberman J; Glenthoj B; Gattaz WF; Thibaut F; Möller HJ;
    World J Biol Psychiatry; 2012 Jul; 13(5):318-78. PubMed ID: 22834451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: long-term treatment of schizophrenia.
    Falkai P; Wobrock T; Lieberman J; Glenthoj B; Gattaz WF; Möller HJ;
    World J Biol Psychiatry; 2006; 7(1):5-40. PubMed ID: 16509050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia. Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactation.
    Hasan A; Falkai P; Wobrock T; Lieberman J; Glenthøj B; Gattaz WF; Thibaut F; Möller HJ;
    World J Biol Psychiatry; 2015 Apr; 16(3):142-70. PubMed ID: 25822804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guidelines for the Pharmacotherapy of Schizophrenia in Adults.
    Remington G; Addington D; Honer W; Ismail Z; Raedler T; Teehan M
    Can J Psychiatry; 2017 Sep; 62(9):604-616. PubMed ID: 28703015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology.
    Barnes TR; Drake R; Paton C; Cooper SJ; Deakin B; Ferrier IN; Gregory CJ; Haddad PM; Howes OD; Jones I; Joyce EM; Lewis S; Lingford-Hughes A; MacCabe JH; Owens DC; Patel MX; Sinclair JM; Stone JM; Talbot PS; Upthegrove R; Wieck A; Yung AR
    J Psychopharmacol; 2020 Jan; 34(1):3-78. PubMed ID: 31829775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A systematic review of clinical guidelines on choice, dose, and duration of antipsychotics treatment in first- and multi-episode schizophrenia.
    Hui CLM; Lam BST; Lee EHM; Chan SKW; Chang WC; Suen YN; Chen EYH
    Int Rev Psychiatry; 2019; 31(5-6):441-459. PubMed ID: 31225767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological guidelines for schizophrenia: a systematic review and comparison of recommendations for the first episode.
    Keating D; McWilliams S; Schneider I; Hynes C; Cousins G; Strawbridge J; Clarke M
    BMJ Open; 2017 Jan; 7(1):e013881. PubMed ID: 28062471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of guidelines for the treatment of schizophrenia.
    Milner KK; Valenstein M
    Psychiatr Serv; 2002 Jul; 53(7):888-90. PubMed ID: 12096176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study.
    Hasegawa N; Yasuda Y; Yasui-Furukori N; Yamada H; Hori H; Ichihashi K; Takaesu Y; Iida H; Muraoka H; Kodaka F; Iga JI; Hashimoto N; Ogasawara K; Ohi K; Fukumoto K; Numata S; Tsuboi T; Usami M; Hishimoto A; Furihata R; Kishimoto T; Nakamura T; Katsumoto E; Ochi S; Nagasawa T; Atake K; Kubota C; Komatsu H; Yamagata H; Ide K; Takeshima M; Kido M; Kikuchi S; Okada T; Matsumoto J; Miura K; Shimazu T; Inada K; Watanabe K; Hashimoto R
    Psychiatry Clin Neurosci; 2023 Oct; 77(10):559-568. PubMed ID: 37684711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. “Meta-guidelines” for the management of patients with schizophrenia.
    Stahl SM; Morrissette DA; Citrome L; Saklad SR; Cummings MA; Meyer JM; O'Day JA; Dardashti LJ; Warburton KD
    CNS Spectr; 2013 Jun; 18(3):150-162. PubMed ID: 23591126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Commentary on Galletly et al. (2016), The Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders.
    Sweeney S; Air T
    Aust N Z J Psychiatry; 2017 Mar; 51(3):288-289. PubMed ID: 28218054
    [No Abstract]   [Full Text] [Related]  

  • 35. Antipsychotic treatment in the maintenance phase of schizophrenia: An updated systematic review of the guidelines and algorithms.
    Shimomura Y; Kikuchi Y; Suzuki T; Uchida H; Mimura M; Takeuchi H
    Schizophr Res; 2020 Jan; 215():8-16. PubMed ID: 31784340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects.
    Hasan A; Falkai P; Wobrock T; Lieberman J; Glenthoj B; Gattaz WF; Thibaut F; Möller HJ;
    World J Biol Psychiatry; 2013 Feb; 14(1):2-44. PubMed ID: 23216388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Commentary on Galletly et al. (2016), The Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders.
    Hunter E
    Aust N Z J Psychiatry; 2016 Nov; 50(11):1105-1106. PubMed ID: 27670833
    [No Abstract]   [Full Text] [Related]  

  • 38. Management of depression in patients with schizophrenia spectrum disorders: a critical review of international guidelines.
    Dondé C; Vignaud P; Poulet E; Brunelin J; Haesebaert F
    Acta Psychiatr Scand; 2018 Oct; 138(4):289-299. PubMed ID: 29974451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indicators of conformance with guidelines of schizophrenia treatment in mental health services.
    Bollini P; Pampallona S; Nieddu S; Bianco M; Tibaldi G; Munizza C
    Psychiatr Serv; 2008 Jul; 59(7):782-91. PubMed ID: 18586996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic literature review of schizophrenia clinical practice guidelines on acute and maintenance management with antipsychotics.
    Correll CU; Martin A; Patel C; Benson C; Goulding R; Kern-Sliwa J; Joshi K; Schiller E; Kim E
    Schizophrenia (Heidelb); 2022 Feb; 8(1):5. PubMed ID: 35210430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.